Dementia video series
Video: an introduction to dementia
Watch these videos to learn about dementia from an expert and how to reduce the risk of developing this condition.
Video: signs and diagnosis of dementia
These videos explain early warning signs of dementia, when to talk with your doctor and how dementia is diagnosed.
Video: dementia treatments and research
These videos cover treatment options for dementia, what can be done to delay its progression and dementia research.
Video: caring for someone with dementia
Watch these videos for advice on care options for people with dementia, and to find out what help is available for dementia carers.
Video: Aboriginal and Torres Strait Islander peoples and dementia
Watch Dr Mark Wenitong, a leader in Indigenous health, sharing insights on dementia management for Aboriginal and Torres Strait Islander peoples.
Need more information?
These trusted information partners have more on this topic.
Top results
Dementia Australia | The Dementia Guide
*/ The Dementia Guide, a friend to support people living with dementia and carers.
Read more on Dementia Australia website
Dementia (Alzheimer's disease) information video | myVMC
Living with dementia and providing dementia care can be difficult. Watch tips and advice from doctors and people with Alzheimers disease in this video.
Read more on myVMC – Virtual Medical Centre website
Dementia Australia | For people with dementia - SA
The Community Programs Team offer a range of services designed to support the specific needs of people living with dementia.
Read more on Dementia Australia website
Dementia Australia | Support for people with dementia in ACT
Dementia Australia ACT offers a range of services for people living with dementia or those concerned about increasing lapses of memory.
Read more on Dementia Australia website
Dementia Australia | Dementia In My Family
Dementia in My Family offers valuable resources and information for children and adults who either know someone living with dementia or have dementia in the family.
Read more on Dementia Australia website
Dementia Australia | Planning for the future
Money matters Make sure that all your important documents such as insurance policies, mortgage and financial papers are the way you want them to be. Tell someone you trust where they are kept. In most states and territories, a person can sign a document called an 'enduring power of attorney'. An enduring power of attorney is a legal arrangement that enables a nominated person to look after your financial affairs if you become unable to do so.
Read more on Dementia Australia website
Dementia Australia | For people with dementia
Dementia Australia offers a range of education programs designed to support the specific needs of people living with dementia. Living with dementia program If you are living with early stage dementia or are a family carer for someone with dementia, you are welcome to join our early intervention program. You will get information and support through sharing your experiences with a small goup of others in a similar situation.
Read more on Dementia Australia website
Dementia Australia | Engage, Enable, Empower
Watch and read about the experiences of people living with dementia. Meet people like Trish (pictured), who wish to share their story so that they can help others living with a diagnosis of dementia.
Read more on Dementia Australia website
Dementia Australia | Dementia Friendly Home app
The Dementia-Friendly Home app provides carers with ideas to make their home more accessible for people living with dementia. With 70% of people with dementia living in the community, the app enables the home to be made more dementia-friendly. This can allow the person to stay in their own home, enjoy their regular lifestyle activities and remain engaged with their community for longer.
Read more on Dementia Australia website
Dementia Australia | Dementia-Friendly Home app
The Dementia-Friendly Home App in now available for tablets and mobile phones. Using interactive 3D game technology Unreal Engine, the app provides carers with ideas to make their home more accessible for people living with dementia.
Read more on Dementia Australia website
Top results
Limited evidence that propentofylline benefits cognition, global function and activities of daily living in people with Alzheimer's disease and/or vascular dementia | Cochrane
Limited evidence that propentofylline benefits cognition, global function and activities of daily living in people with Alzheimer's disease and/or vascular dementia
Read more on Cochrane (Australasian Centre) website
Respite care for people with dementia and their carers | Cochrane
This review aims to see whether respite care can reduce caregiver burden and stress, and increase the length of time for which a person with dementia can continue living at home.
Read more on Cochrane (Australasian Centre) website
Exercise programs for people with dementia | Cochrane
In future, as the population ages, the number of people in our communities suffering with dementia will rise dramatically. This will not only affect the quality of life of people with dementia but also increase the burden on family caregivers, community care, and residential care services. Exercise is one lifestyle factor that has been identified as a potential means of reducing or delaying progression of the symptoms of dementia.
Read more on Cochrane (Australasian Centre) website
Evidence of some short-term benefit of nimodipine for people with dementia | Cochrane
The efficacy of nimodipine, a calcium channel blocker, has been tested in randomized controlled trials for the treatment of dementia, particularly Alzheimer's disease and multi-infarct dementia, the commonest forms of dementia in older people. The rationale for its use is to restrict the influx of calcium ions into neurons, and, by vasodilatation, to improve blood flow to the brain. This review found evidence of some short-term benefit attributable to nimodipine, mainly in measures of cognitive function and global impression, but not in activities on daily living, for patients with degenerative and multi-infarct dementia, and mixed dementia. Nimodipine is well tolerated with a low rate of adverse effects similar to that associated with placebo.
Read more on Cochrane (Australasian Centre) website
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia | Cochrane
Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
Read more on Cochrane (Australasian Centre) website
Rehabilitation for people with dementia following a hip fracture operation | Cochrane
Hip fracture is an injury primarily of elderly people, usually caused by a fall. It can affect a person's ability to walk, perform activities of daily living and remain independent. Hip fracture is more common in people with dementia and they can find it more difficult to recover. This is because they are at greater risk of becoming more confused and developing additional complications such as pressure sores and chest infections after their operation. They may also find it more difficult to express their pain and discomfort.
Read more on Cochrane (Australasian Centre) website
Cholinesterase inhibitors are beneficial for people with Parkinson's disease and dementia | Cochrane
The clinical features of dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) have much in common. As patients with DLB and PDD have particularly severe deficits in cortical levels of the neurotransmitter acetylcholine, blocking its breakdown using a group of chemicals known as cholinesterase inhibitors may lead to clinical improvement. Six trials showed a statistically significant improvement in global assessment, cognitive function, behavioural disturbance and activities of daily living rating scales in PDD and cognitive impairment in Parkinson's disease (CIND-PD) patients treated with cholinesterase inhibitors. There was no current disaggregated evidence to support their use in CIND-PD. In a single trial, no statistically significant improvement was observed in patients with DLB who were treated with cholinesterase inhibitors and further trials are necessary to clarify the effect of cholinesterase inhibitors in this patient group.
Read more on Cochrane (Australasian Centre) website
Donepezil is beneficial for people with mild, moderate and severe dementia due to Alzheimer's disease | Cochrane
Donepezil is beneficial for people with mild, moderate and severe dementia due to Alzheimer's disease
Read more on Cochrane (Australasian Centre) website
[Cholinesterase inhibitors for rarer dementia associated with neurological conditions] | Cochrane
There are various rarer dementias including Huntington's disease (HD), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), frontotemporal dementia (FTD), dementia in multiple sclerosis (MS) and progressive supranuclear palsy (PSP). A group of chemicals known as cholinesterase inhibitors are considered to be the first-line medicines for Alzheimer's disease and some other dementias. Cholinesterase inhibitors may also lead to clinical improvement for rarer dementias associated with neurological conditions.
Read more on Cochrane (Australasian Centre) website
11C-PIB-PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI) | Cochrane
11C-PIB-PET scan for early prediction of developing Alzheimers disease or other dementia in people with mild cognitive impairment (MCI)
Read more on Cochrane (Australasian Centre) website
